Compare Biogen Inc (BIIB) vs Wheaton Precious Metals Corp (WPM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Biogen Inc vs Wheaton Precious Metals Corp — how do they compare? Biogen Inc trades at $206.52 (market cap $30.13B), while Wheaton Precious Metals Corp trades at $134.6 (market cap $60.94B). The key difference: Wheaton Precious Metals Corp is far larger — about 2× Biogen Inc's market cap, and Wheaton Precious Metals Corp pays a 0.58% dividend while Biogen Inc pays none. Which is the better fit depends on your goals.
| BIIB | WPM | |
|---|---|---|
Market Cap | $30.13B | $60.94B |
Sector | Health | Basic Materials |
52-Week High | $216.63 | $165.72 |
52-Week Low | $128.93 | $91.02 |
Enterprise Value | $37.20B | $62.82B |
Dividend Yield | — | 0.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Biogen (BIIB) trades at $207.13, down 0.39% on the day, with a bullish technical signal and strong analyst support. Recent Q2 2026 earnings of $3.60 per share beat estimates, driven by growth in Alzheimer's and rare disease portfolios, though revenue growth remains modest. The company completed the acquisition of RayThera Inc. in August 2026, enhancing its immunology pipeline. Cash flow from operations remains healthy at $2.20 billion for 2025, supporting strategic investments.
The outlook is positive with a consensus price target of $234.47, implying ~13% upside, but risks include competitive pressures in multiple sclerosis drugs and execution challenges from recent acquisitions. Net income margin compression to 8.32% in 2026 warrants monitoring, though institutional buying and bullish analyst ratings (62.5% Buy) signal confidence in the turnaround story.
Wheaton Precious Metals (WPM) trades at $135.51, up 1.59% on the day, reflecting strong momentum amid record financial performance. The stock exhibits a bullish technical trend, supported by consecutive earnings beats and robust cash flow growth. Recent results highlight significant revenue and profit expansion, driven by higher metal prices and increased sales volumes. Analyst sentiment remains overwhelmingly positive, with a consensus Buy rating and a price target implying substantial upside potential.
The outlook for WPM is favorable, underpinned by its high-margin streaming model and exposure to rising precious metal prices. Key opportunities include sustained earnings growth and strategic deal capacity, while risks involve commodity price volatility and execution of future streaming agreements. The stock's current valuation multiples suggest premium pricing, requiring continued operational excellence to justify further appreciation.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Biogen Inc
Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva are marketed via a collaboration with Roche. Biogen also markets novel MS drugs Plegridy, Tysabri, Tecfidera, and Vumerity. In Japan, Biogen's MS portfolio is co-promoted by Eisai. Hemophilia therapies Eloctate and Alprolix (partnered with SOBI) were spun off as part of Bioverativ in 2017. Biogen has several drug candidates in phase 3 trials in neurology and neurodegenerative diseases and has launched Spinraza with partner Ionis. Aduhelm was approved as the firm's first Alzheimer's disease therapy in June 2021.
Read more on BIIB →About Wheaton Precious Metals Corp
Wheaton Precious Metals Corp is a precious metal streaming company. The company has entered into over 20 long-term purchase agreements with 17 different mining companies, for the purchase of precious metals and cobalt. It has streaming agreements covering approximately 19 operating mines and 9 development stage projects. The company's projects include Vale's Salobo mine and silver streams on Glencore's Antamina mine and Goldcorp's Penasquito mine.
Read more on WPM →
